Lv1
40 积分 2025-09-20 加入
Discovery of survival predictor and early monitoring biomarkers for EGFR tyrosine kinase inhibitor therapy in lung adenocarcinoma by integrative omics analysis
2个月前
已关闭
μPharma: A microfluidic, AI-driven pharmacotyping platform for single-cell drug sensitivity prediction in leukemia
2个月前
已完结
Repurposing chlorpromazine for the treatment of triple-negative breast cancer growth and metastasis based on modulation of mitochondria-mediated apoptosis and autophagy/mitophagy
11个月前
已完结
Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities
11个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
11个月前
已完结
Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?
11个月前
已完结
皖公网安备34019202002308
